J.K. Rowling's name has become synonymous with her legendary "Harry Potter" book series, but she is also famous for something more controversial: her public and often contentious views on the ...
A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial, as the drugmaker tries to fend off a marketplace challenge from Eli Lilly. A 7.2mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback